XML 74 R75.htm IDEA: XBRL DOCUMENT v3.19.3
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 28, 2018
Sep. 30, 2019
Sep. 28, 2018
Dec. 31, 2018
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 1,474,261   $ 1,474,261   $ 1,488,807
Total assets 3,362,644   3,362,644   2,612,578
Current liabilities 1,156,259   1,156,259   1,006,161
Total liabilities 1,768,193   1,768,193   1,657,345
Total joint venture equity (1,010,654)   (1,010,654)   (967,537)
Investments in and advances to unconsolidated joint ventures 66,584   66,584   63,560
Revenues 1,023,277 $ 976,157 2,917,424 $ 2,631,568  
Costs 798,552 783,018 2,297,512 2,054,201  
Net income attributable to Parsons Corporation 56,812 41,222 106,812 214,890  
Equity in earnings of unconsolidated joint ventures 7,274 12,707 29,305 25,577  
Unconsolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 778,876   778,876   707,457
Noncurrent assets 956,367   956,367   876,385
Total assets 1,735,243   1,735,243   1,583,842
Current liabilities 625,949   625,949   560,306
Noncurrent liabilities 895,514   895,514   813,269
Total liabilities 1,521,463   1,521,463   1,373,575
Total joint venture equity 213,780   213,780   210,267
Investments in and advances to unconsolidated joint ventures 66,584   66,584   $ 63,560
Revenues 474,600 482,634 1,225,284 1,234,946  
Costs 452,001 462,042 1,166,008 1,186,184  
Net income attributable to Parsons Corporation 22,599 20,592 59,276 48,762  
Equity in earnings of unconsolidated joint ventures $ 7,274 $ 12,707 $ 29,305 $ 25,577